(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.
(CIDRAP News) – Agriculture officials in South Korea today confirmed that large numbers of chicken deaths at a commercial farm in the southwestern part of the country were caused by H5N1 avian influenza.
(CIDRAP News) A 52-year-old Chinese man probably caught H5N1 avian influenza from his dying son while caring for him in a hospital last December, but others who had close contact with both patients were not infected, Chinese researchers reported this week in The Lancet.
(CIDRAP News) Japan's health ministry today said it was on the verge of approving a plan to administer prepandemic vaccine to healthcare workers, which would make it the world's first country to tap its national stockpile for this purpose.
(CIDRAP News) – US Health and Human Services (HHS) Secretary Mike Leavitt, in Vietnam today on the second leg of a 10-daytour of Southeast Asia, revealed new details on his blog today about his talks with Indonesian officials on two controversial issues: the country's refusal to freely share H5N1 virus samples and the status of the US Navy's medical laboratory unit, NAMRU-2.
(CIDRAP News) A US Department of Health and Human Services (HHS) official today shared wrap-up perspectives on HHS Secretary Mike Leavitt's recent trip to Southeast Asia, which included discussions on virus-sharing and restrictions on the US Navy laboratory in Indonesia, updates on avian influenza collaborations, and talks on import safety.
(CIDRAP News) Animal health officials in Japan were awaiting final tests on four wild swans that recently tested positive for an H5 strain of avian influenza, as authorities in Vietnam and India's Tripura state moved to quash new outbreaks caused by the highly pathogenic H5N1 virus.
(CIDRAP News) – The US Department of Health and Human Services (HHS) has accepted the first batch of H5N1 avian influenza vaccine based on the H5N1 variant known as clade 2.2, which has spread most widely across Asia, Europe, and Africa.